A Promising Target to Treat Asthma, University of Iowa Study

Published: Jul 25, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms. The finding could lead to the development of a drug that would target the CaMKII enzyme, the researchers say.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news